Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 5/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.62 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.62 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.62 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.62 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.62 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.61 |
| ▸ | KDM1A | O60341 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CDK9 | P50750 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopropane SCHEMBL27484508 | 0.94 | EPHX2 (0.59) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL27783378 | 0.94 | HDAC4 (0.57) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL20067991 | 0.92 | MAPT (0.68) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL15267699 | 0.88 | KMT2A (0.60) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL16197808 | 0.88 | ALDH1A1 (0.68) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL3986889 | 0.85 | EPHX2 (0.55) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL21765844 | 0.84 | POLB (0.56) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL1689206 | 0.83 | EPHX2 (0.68) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL4262750 | 0.83 | RNF4 (0.71) | HDAC4HDAC1HDAC7HDAC11HDAC8 | |
| SCHEMBL1573386 | 0.83 | L3MBTL1 (0.63) | HDAC4HDAC1HDAC7HDAC11HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025074340-A1 | A PROCESS FOR PREPARATION OF AMINOBIPHENYL COMPOUNDS AND INTERMEDIATES THEREOF | UPL LIMITED (IN) | 2025-04-10 | — | — | WO | claimed |
| CN-119306720-A | Evodiamine derivative, rutaecarpine derivative, preparation method and application thereof | 济宁市第一人民医院(济宁市医学科学研究院) | 2025-01-14 | — | — | CN | claimed |
| EP-2560634-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | Piramal Enterprises Limited (IN) | 2013-02-27 | — | — | EP | claimed |
| CN-101525304-B | Preparation method for nitrogen-chloro acetanilide containing halogenated functional group | UNIV WUHAN | 2012-07-04 | — | — | CN | claimed |
| WO-2011132171-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-10-27 | — | — | WO | claimed |
| CN-101525304-A | Preparation method for nitrogen-chloro acetanilide containing halogenated functional group | UNIV WUHAN | 2009-09-09 | — | — | CN | claimed |
| EP-1885348-A2 | ANTIPYRETIC AGENTS AGAINST VR1-ANTAGONIST-INDUCED INCREASES IN BODY TEMPERATURE | Amgen, Inc (US) | 2008-02-13 | — | — | EP | claimed |
| WO-2006124753-A2 | ANTIPYRETIC AGENTS AGAINST VR1-ANTAGONIST-INDUCED INCREASES IN BODY TEMPERATURE | AMGEN INC. (US) | 2006-11-23 | — | — | WO | claimed |
| US-5159082-A | Catalytic coupling of an aromatic sulfinic acid with an aromatic halogen compound | MITSUBISHI KASEI CORPORATION (JP) | 1992-10-27 | — | — | US | claimed |
| EP-0405389-A1 | Process for producing an aromatic compound | Mitsubishi Chemical Corporation (JP) | 1991-01-02 | — | — | EP | claimed |
| EP-0081384-B1 | PROCESS FOR THE PREPARATION OF AROMATIC OR HETEROAROMATIC CARBOXYLATED COMPOUNDS | Montedison S.p.A. (IT) | 1986-04-02 | — | — | EP | claimed |
| EP-4061961-B1 | METHOD FOR DOUBLE STRAND SEQUENCING | OXFORD NANOPORE TECH PLC (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-20260072008-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | UNIV OXFORD INNOVATION LTD (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | Oxford Nanopore Technolgies PLC (GB) | 2026-03-05 | — | — | US | disclosed |
| US-3937730-A | N-ALKOXY-N-CHLOROACETANILIDE | CIBA-GEIGY CORPORATION (US) | 1976-02-10 | — | — | US | disclosed |
| US-3898273-A | Esterified bromoacetanilides | AKZO AMERICA INC., A CORP. OF DE | 1975-08-05 | — | — | US | disclosed |
| US-3898273-A | Esterified bromoacetanilides | AKZO AMERICA INC., A CORP. OF DE | 1975-08-05 | — | — | US | disclosed |
| US-3892786-A | Bromoacetanilides and their utility as biocides | STAUFFER CHEMICAL CO | 1975-07-01 | — | — | US | disclosed |
| US-3892786-A | Bromoacetanilides and their utility as biocides | STAUFFER CHEMICAL CO | 1975-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260072008-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | MAX, NPPA, NUP210 | HDAC4 4766/4885HDAC1 4868/4885HDAC7 4802/4885 |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, NPPA, NUP160 | HDAC4 4844/4885HDAC1 4883/4885HDAC7 4842/4885 |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, SLC9A2, SLC9A3 | HDAC4 4868/4885HDAC1 4879/4885HDAC7 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.